In addition, several miRNAs have been found in the host serum [26–29] (Fig. 1) For instance, miR-184 may control the metastasis in triple-negative breast cancer by targeting the AKT/mammalian/mechanistic target of rapamycin (mTOR) pathway to cancer cell proliferation, invasion, and migration [31]. Here, MTOR is linked to cancer.